Angiotensin-I-converting enzyme inhibitors—which can reduce the activity of the angiotensin-I-converting enzyme (ACE)—have an antihypertensive effect in vivo, and play a key role in the treatment of the hypertension [2]. This evidence concerns the gene ACE and hypertensive disorder.